Genovis AB (publ.)

Genovis AB (publ.)

GEOVF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.56B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Genovis AB (publ.)Genovis AB (publ.)97.6-5%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.56 Billion
Enterprise Value$1.40 Billion
Earnings per Share$-
Beta1.57
Outstanding Shares-

Return

Return on Equity5.30%ROE
Return on Assets3.76%
Return on Invested Capital5.65%

Valuation & Multiples

P/E Ratio97.64P/E Ratio
PEG-202.87PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue9.39
Enterprise Value to EBIT62.22
Enterprise Value to Net Income83
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Genovis AB

42 employees
CEO: Fredrik Olsson

Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cyste...